Phase 1 study of IMCnyeso, a T cell receptor bispecific ImmTAC targeting NY-ESO-1-expressing malignancies
Titel:
Phase 1 study of IMCnyeso, a T cell receptor bispecific ImmTAC targeting NY-ESO-1-expressing malignancies
Auteur:
Lopez, Juanita S. Milhem, Mohammed Butler, Marcus O. Thistlethwaite, Fiona Van Tine, Brian A. D’Angelo, Sandra P. Johnson, Melissa L. Sato, Takami Arkenau, Hendrik-Tobias Edukulla, Ramakrishna Wustner, Jason Marshall, Shannon Rodon, Jordi